Carcinogenesis Advance Access published online on February 7, 2008
Carcinogenesis, doi:10.1093/carcin/bgn026
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAK AND IGF-IR INTERACT TO PROVIDE SURVIVAL SIGNALS IN HUMAN PANCREATIC ADENOCARCINOMA CELLS
1 Division of Surgical Oncology, University of Florida College of Medicine
2 Department of Biochemistry and Molecular and Cell Biology, University of Florida College of Medicine
3 Department of Molecular Genetics and Microbiology, University of Florida College of Medicine
Corresponding author: Steven N. Hochwald, M.D., University of Florida College of Medicine, P.O. Box 100286, Gainesville, FL 32610, Tel. 352 265-0169; Fax 352 265-0262; E-mail: steven.hochwald{at}surgery.ufl.edu
Pancreatic cancer is a lethal disease accounting for the fourth leading cause of cancer death in the United States. Focal adhesion kinase (FAK) and the insulin-like growth factor-I receptor (IGF-1R) are tyrosine kinases that activate common pathways, leading to increased proliferation and cell survival. Sparse information is available regarding their contribution to the malignant behavior of pancreatic cancer. We analyzed the relationship between FAK and IGF-1R in human pancreatic cancer cells, determined which downstream signaling pathways are altered following kinase inhibition or downregulation and studied whether dual kinase inhibition represents a potential novel treatment strategy in this deadly disease. Using immunoprecipitation and confocal microscopy, we show for the first time that FAK and IGF-1R physically interact in pancreatic cancer cells and that inhibition of tyrosine phosphorylation of either kinase disrupts their interaction. Decreasing phosphorylation of either FAK or IGF-1R alone resulted in little inhibition of cell viability or increased apoptosis. However, dual inhibition of FAK, using either a dominant negative construct (FAK-CD) or siRNA, and IGF-1R, using a specific small molecule tyrosine kinase inhibitor (AEW-541) or stable expression of a truncated, mutated IGF-1R, led to a synergistic decrease in cell proliferation and phosphorylation of ERK and increase in cell detachment and apoptosis, compared to inhibition of either pathway alone. Dual kinase inhibition with FAK-CD and AEW-541 resulted in a marked increase in apoptosis when FAK was displaced from the focal adhesions. Inhibition of both tyrosine kinase activities via a novel single small molecular inhibitor (TAE 226), at low doses specific for FAK and IGF-1R, resulted in significant inhibition of cell viability, decrease in phosphorylation of ERK and Akt and increase in apoptosis accompanied by cleavage of PARP and activation of caspase-3 in pancreatic cancer cells. Thus, simultaneous inhibition of both tyrosine kinases represents a potential novel therapeutic approach in human pancreatic adenocarcinoma.
Key Words: FAK • IGF-IR • pancreatic cancer • signal transduction • apoptosis
* WL and DAB contributed equally to this work.
Received September 7, 2007; revised December 28, 2007; accepted January 19, 2008.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. W. Miller, M. Perez-Torres, A. Narasanna, M. Guix, O. Stal, G. Perez-Tenorio, A. M. Gonzalez-Angulo, B. T. Hennessy, G. B. Mills, J. P. Kennedy, et al. Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer Cancer Res., May 15, 2009; 69(10): 4192 - 4201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Legate, S. A. Wickstrom, and R. Fassler Genetic and cell biological analysis of integrin outside-in signaling Genes & Dev., February 15, 2009; 23(4): 397 - 418. [Abstract] [Full Text] [PDF]
|
|